{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:15:06Z","timestamp":1793366106529,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["No. 2023ZD0508100, 2023ZD0508103"],"award-info":[{"award-number":["No. 2023ZD0508100, 2023ZD0508103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02412-w","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:04:58Z","timestamp":1783764298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Novel phenotypic clusters of adult-onset diabetic kidney disease based on static and dynamic clustering algorithms - a data-driven multi-center study"],"prefix":"10.1186","volume":"26","author":[{"given":"Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiubo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0815-5627","authenticated-orcid":false,"given":"Longyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"2412_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003428","author":"J Li","year":"2025","unstructured":"Li J, Guo K, Qiu J, Xue S, Pi L, Li X, et al. Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: A systematic analysis of Global Burden of Disease Study 2021. Chin Med J (Engl). 2025. https:\/\/doi.org\/10.1097\/CM9.0000000000003428.","journal-title":"Chin Med J (Engl)"},{"key":"2412_CR2","doi-asserted-by":"publisher","first-page":"2315607","DOI":"10.1155\/2020\/2315607","volume":"2020","author":"X Zhang","year":"2020","unstructured":"Zhang X, Kong J, Yun K. Prevalence of Diabetic Nephropathy among Patients with Type 2 Diabetes Mellitus in China: A Meta-Analysis of Observational Studies. J Diabetes Res. 2020;2020:2315607. https:\/\/doi.org\/10.1155\/2020\/2315607.","journal-title":"J Diabetes Res"},{"key":"2412_CR3","doi-asserted-by":"publisher","first-page":"925","DOI":"10.2337\/dc19-1897","volume":"43","author":"W Jiang","year":"2020","unstructured":"Jiang W, Wang J, Shen X, Lu W, Wang Y, Li W, et al. Establishment and Validation of a Risk Prediction Model for Early Diabetic Kidney Disease Based on a Systematic Review and Meta-Analysis of 20 Cohorts. Diabetes Care. 2020;43:925\u201333. https:\/\/doi.org\/10.2337\/dc19-1897.","journal-title":"Diabetes Care"},{"key":"2412_CR4","doi-asserted-by":"publisher","first-page":"1407348","DOI":"10.3389\/fendo.2024.1407348","volume":"15","author":"W Xu","year":"2024","unstructured":"Xu W, Zhou Y, Jiang Q, Fang Y, Yang Q. Risk prediction models for diabetic nephropathy among type 2 diabetes patients in China: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024;15:1407348. https:\/\/doi.org\/10.3389\/fendo.2024.1407348.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2412_CR5","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3760\/cma.j.cn115791-20241231-00768","volume":"17","author":"Expert Consensus on Early Screening and Management of Diabetic Kidney Disease Writing Group Expert consensus","year":"2025","unstructured":"Expert Consensus on Early Screening and Management of Diabetic Kidney Disease Writing Group Expert consensus. on early screening and management of diabetic kidney disease (2025 edition). Chin J Diabetes Mellitus. 2025;17:786\u2013800. https:\/\/doi.org\/10.3760\/cma.j.cn115791-20241231-00768.","journal-title":"Chin J Diabetes Mellitus"},{"key":"2412_CR6","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/s41581-021-00462-y","volume":"17","author":"M Oshima","year":"2021","unstructured":"Oshima M, Shimizu M, Yamanouchi M, Toyama T, Hara A, Furuichi K, et al. Trajectories of kidney function in diabetes: a clinicopathological update. Nat Rev Nephrol. 2021;17:740\u201350. https:\/\/doi.org\/10.1038\/s41581-021-00462-y.","journal-title":"Nat Rev Nephrol"},{"key":"2412_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12933-023-02065-2","volume":"22","author":"M Di Marco","year":"2023","unstructured":"Di Marco M, Scilletta S, Miano N, Marrano N, Natalicchio A, Giorgino F, et al. Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease. Cardiovasc Diabetol. 2023;22:344. https:\/\/doi.org\/10.1186\/s12933-023-02065-2.","journal-title":"Cardiovasc Diabetol"},{"key":"2412_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-025-06594-1","author":"K Watanabe-Shimoji","year":"2025","unstructured":"Watanabe-Shimoji K, Tanabe H, Ohsugi M, Kawakami E, Tanaka K, Kazama JJ, et al. Diverse combination of factors associated with the development of diabetic kidney disease among data-driven diabetes subtypes: analysis of the J-DREAMS registry. Diabetologia. 2025. https:\/\/doi.org\/10.1007\/s00125-025-06594-1.","journal-title":"Diabetologia"},{"key":"2412_CR9","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361\u20139. https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2412_CR10","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1038\/s41591-024-03283-1","volume":"30","author":"V Raverdy","year":"2024","unstructured":"Raverdy V, Tavaglione F, Chatelain E, Lassailly G, De Vincentis A, Vespasiani-Gentilucci U, et al. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease. Nat Med Nat Publishing Group. 2024;30:3624\u201333. https:\/\/doi.org\/10.1038\/s41591-024-03283-1.","journal-title":"Nat Med Nat Publishing Group"},{"key":"2412_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/CLEP.S265287","volume":"12","author":"HL Nguena Nguefack","year":"2020","unstructured":"Nguena Nguefack HL, Pag\u00e9 MG, Katz J, Choini\u00e8re M, Vanasse A, Dorais M, et al. Trajectory Modelling Techniques Useful to Epidemiological Research: A Comparative Narrative Review of Approaches. Clin Epidemiol. 2020;12:1205\u201322. https:\/\/doi.org\/10.2147\/CLEP.S265287.","journal-title":"Clin Epidemiol"},{"key":"2412_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/jep.12934","volume":"24","author":"A Linden","year":"2018","unstructured":"Linden A. Using group-based trajectory modelling to enhance causal inference in interrupted time series analysis. J Eval Clin Pract. 2018;24:502\u20137. https:\/\/doi.org\/10.1111\/jep.12934.","journal-title":"J Eval Clin Pract"},{"key":"2412_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1753-0407.12847","volume":"11","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Wang W, Ning G. Metabolic Management Center: An innovation project for the management of metabolic diseases and complications in China. J Diabetes. 2019;11:11\u20133. https:\/\/doi.org\/10.1111\/1753-0407.12847.","journal-title":"J Diabetes"},{"key":"2412_CR14","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385:1737\u201349. https:\/\/doi.org\/10.1056\/NEJMoa2102953.","journal-title":"N Engl J Med"},{"key":"2412_CR15","doi-asserted-by":"publisher","first-page":"e70007","DOI":"10.1002\/inm3.70007","volume":"2","author":"Z Wang","year":"2026","unstructured":"Wang Z, Su M, Li Y, Li Y, Chen S, Peng T, et al. Metabolic Signatures and Diagnostic Prediction Models for Coronary Artery Disease and Type 2 Diabetes Mellitus: Insights From an Exploratory Study. iNew Med. 2026;2:e70007. https:\/\/doi.org\/10.1002\/inm3.70007.","journal-title":"iNew Med"},{"key":"2412_CR16","doi-asserted-by":"publisher","first-page":"e70000","DOI":"10.1002\/inm3.70000","volume":"1","author":"Z Wang","year":"2025","unstructured":"Wang Z, Chen S, Xu S, Weng J. Risk Factors for Cardiovascular and Metabolic Disease: Integrating Traditional and Novel Paradigms. iNew Med. 2025;1:e70000. https:\/\/doi.org\/10.1002\/inm3.70000.","journal-title":"iNew Med"},{"key":"2412_CR17","doi-asserted-by":"publisher","unstructured":"Gong Z, Laporte JP, Guo AY, Bilgel M, Bae J, Fox NY, et al. Early axonal degeneration linked to clinical decline in Alzheimer\u2019s disease progression revealed with diffusion MRI. J Clin Invest. 2025;e196638. https:\/\/doi.org\/10.1172\/JCI196638.","DOI":"10.1172\/JCI196638"},{"key":"2412_CR18","doi-asserted-by":"publisher","unstructured":"Kreienkamp RJ, Smith K, Wangden TY, Deutsch AJ, Gage SD, Bellatorre A, et al. Novel phenotypic clusters of youth-onset type 2 diabetes offer no added prognostic value to simple clinical measures. Diabetes Care. 2025;dc251765. https:\/\/doi.org\/10.2337\/dc25-1765.","DOI":"10.2337\/dc25-1765"},{"key":"2412_CR19","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1007\/s00125-022-05741-2","volume":"65","author":"J Wang","year":"2022","unstructured":"Wang J, Liu J-J, Gurung RL, Liu S, Lee J, M Y, et al. Clinical variable-based cluster analysis identifies novel subgroups with a distinct genetic signature, lipidomic pattern and cardio-renal risks in Asian patients with recent-onset type 2 diabetes. Diabetologia. 2022;65:2146\u201356. https:\/\/doi.org\/10.1007\/s00125-022-05741-2.","journal-title":"Diabetologia"},{"key":"2412_CR20","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","volume":"316","author":"M Afkarian","year":"2016","unstructured":"Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988\u20132014. JAMA. 2016;316:602\u201310. https:\/\/doi.org\/10.1001\/jama.2016.10924.","journal-title":"JAMA"},{"key":"2412_CR21","doi-asserted-by":"publisher","unstructured":"Schumacher LM, Bass SB, Ard J, Rubin DJ, Herring SJ, Rao AD, et al. The new obesity treatment landscape: challenges and opportunities to promote shared decision-making in people with obesity and type 2 diabetes. Diabetes Care. 2025;dci250094. https:\/\/doi.org\/10.2337\/dci25-0094.","DOI":"10.2337\/dci25-0094"},{"key":"2412_CR22","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1042\/CS20210627","volume":"136","author":"KL Tommerdahl","year":"2022","unstructured":"Tommerdahl KL, Kendrick J, Nelson RG, Bjornstad P. Youth versus adult-onset type 2 diabetic kidney disease: Insights into currently known structural differences and the potential underlying mechanisms. Clin Sci (Lond). 2022;136:1471\u201383. https:\/\/doi.org\/10.1042\/CS20210627.","journal-title":"Clin Sci (Lond)"},{"key":"2412_CR23","doi-asserted-by":"publisher","first-page":"e70026","DOI":"10.1002\/inm3.70026","volume":"2","author":"H Liang","year":"2026","unstructured":"Liang H, Wang Y, Zhang Y, Tang X. A Senolytic Strategy for Metabolic Health: Why the Endothelium Matters. iNew Med. 2026;2:e70026. https:\/\/doi.org\/10.1002\/inm3.70026.","journal-title":"iNew Med"},{"key":"2412_CR24","doi-asserted-by":"publisher","first-page":"e70015","DOI":"10.1002\/inm3.70015","volume":"2","author":"S Zhang","year":"2026","unstructured":"Zhang S. GDF15: Anxiety Signalling From the Adipose Tissue. iNew Med. 2026;2:e70015. https:\/\/doi.org\/10.1002\/inm3.70015.","journal-title":"iNew Med"},{"key":"2412_CR25","doi-asserted-by":"publisher","first-page":"e70001","DOI":"10.1002\/inm3.70001","volume":"1","author":"Z Li","year":"2025","unstructured":"Li Z, Dai Y, Ge J. Panvascular Disease: Opportunities and Challenges. iNew Med. 2025;1:e70001. https:\/\/doi.org\/10.1002\/inm3.70001.","journal-title":"iNew Med"},{"key":"2412_CR26","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.2337\/dc18-0277","volume":"41","author":"B Warren","year":"2018","unstructured":"Warren B, Rebholz CM, Sang Y, Lee AK, Coresh J, Selvin E, et al. Diabetes and Trajectories of Estimated Glomerular Filtration Rate: A Prospective Cohort Analysis of the Atherosclerosis Risk in Communities Study. Diabetes Care. 2018;41:1646\u201353. https:\/\/doi.org\/10.2337\/dc18-0277.","journal-title":"Diabetes Care"},{"key":"2412_CR27","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1681\/ASN.2016060666","volume":"28","author":"L Tonneijck","year":"2017","unstructured":"Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH, et al. Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment. J Am Soc Nephrol. 2017;28:1023\u201339. https:\/\/doi.org\/10.1681\/ASN.2016060666.","journal-title":"J Am Soc Nephrol"},{"key":"2412_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/j.ajkd.2017.08.010","volume":"71","author":"M Weldegiorgis","year":"2018","unstructured":"Weldegiorgis M, de Zeeuw D, Li L, Parving H-H, Hou FF, Remuzzi G, et al. Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy. Am J Kidney Dis. 2018;71:91\u2013101. https:\/\/doi.org\/10.1053\/j.ajkd.2017.08.010.","journal-title":"Am J Kidney Dis"},{"key":"2412_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jdiacomp.2019.02.002","volume":"33","author":"T Moriya","year":"2019","unstructured":"Moriya T, Yamagishi T, Matsubara M, Ouchi M. Serial renal biopsies in normo- and microalbuminuric patients with type 2 diabetes demonstrate that loss of renal function is associated with a reduction in glomerular filtration surface secondary to mesangial expansion. J Diabetes Complications. 2019;33:368\u201373. https:\/\/doi.org\/10.1016\/j.jdiacomp.2019.02.002.","journal-title":"J Diabetes Complications"},{"key":"2412_CR30","doi-asserted-by":"publisher","unstructured":"American Diabetes Association Professional Practice Committee. 11. Chronic kidney disease and risk management: standards of care in diabetes-2024. Diabetes Care. 2024;47:S219\u201330. https:\/\/doi.org\/10.2337\/dc24-S011.","DOI":"10.2337\/dc24-S011"},{"key":"2412_CR31","doi-asserted-by":"publisher","unstructured":"Moedt E, Coca SG, Edwards K, Neuen BL, Arnott C, Bakker SJL, et al. Baseline risk and longitudinal changes in kidneyintelX.dkd and its association with kidney outcomes in the CANVAS and CREDENCE trials. Diabetes Care. 2025;dc251722. https:\/\/doi.org\/10.2337\/dc25-1722.","DOI":"10.2337\/dc25-1722"},{"key":"2412_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.2147\/DMSO.S394607","volume":"16","author":"J Ke","year":"2023","unstructured":"Ke J, Li K, Cao B. A Nomogram for Predicting Vision-Threatening Diabetic Retinopathy Among Mild Diabetic Retinopathy Patients: A Case-Control and Prospective Study of Type 2 Diabetes. Diabetes Metab Syndr Obes. 2023;16:275\u201383. https:\/\/doi.org\/10.2147\/DMSO.S394607.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2412_CR33","doi-asserted-by":"publisher","first-page":"e191540","DOI":"10.1001\/jamanetworkopen.2019.1540","volume":"2","author":"C Sabanayagam","year":"2019","unstructured":"Sabanayagam C, Chee ML, Banu R, Cheng C-Y, Lim SC, Tai ES, et al. Association of Diabetic Retinopathy and Diabetic Kidney Disease With All-Cause and Cardiovascular Mortality in a Multiethnic Asian Population. JAMA Netw Open. 2019;2:e191540. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.1540.","journal-title":"JAMA Netw Open"},{"key":"2412_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14304","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li K, Yuan S, Yu C, Yin R, Wang D, et al. Angiopoietin-like 4 is a potential biomarker for diabetic kidney disease in type 2 diabetes patients. J Diabetes Investig. 2024. https:\/\/doi.org\/10.1111\/jdi.14304.","journal-title":"J Diabetes Investig"},{"key":"2412_CR35","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfac212","author":"G D\u2019Arrigo","year":"2022","unstructured":"D\u2019Arrigo G, Mallamaci F, Pizzini P, Leonardis D, Tripepi G, Zoccali C. CKD-MBD Biomarkers and CKD Progression: an Analysis by the Joint Model. Nephrol Dial Transpl. 2022. https:\/\/doi.org\/10.1093\/ndt\/gfac212. gfac212.","journal-title":"Nephrol Dial Transpl"},{"key":"2412_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.2337\/db23-0277","volume":"73","author":"SWT Lai","year":"2024","unstructured":"Lai SWT, Hernandez-Castillo C, Gonzalez EDJL, Zoukari T, Talley M, Paquin N, et al. Methylglyoxal Adducts Are Prognostic Biomarkers for Diabetic Kidney Disease in Patients With Type 1 Diabetes. Diabetes. 2024;73:611\u20137. https:\/\/doi.org\/10.2337\/db23-0277.","journal-title":"Diabetes"},{"key":"2412_CR37","doi-asserted-by":"publisher","first-page":"e70036","DOI":"10.1002\/inm3.70036","volume":"2","author":"Y Chen","year":"2026","unstructured":"Chen Y, Ya R, Zhang Z, Dong S, Park SH, Seo W, et al. N6-Methyladenosine (m6A) in Liver Disease: Pathogenic Mechanisms and Therapeutic Potential. iNew Med. 2026;2:e70036. https:\/\/doi.org\/10.1002\/inm3.70036.","journal-title":"iNew Med"},{"key":"2412_CR38","doi-asserted-by":"publisher","unstructured":"Dong Y, Shen X, Jin H, Li X, He H, Meng X. Epigenetic regulation in the pathogenesis of renal inflammation: insights and therapeutic potentials. iNew Medicine. n\/a:e70012. https:\/\/doi.org\/10.1002\/inm3.70012.","DOI":"10.1002\/inm3.70012"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02412-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02412-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02412-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:02:54Z","timestamp":1791378174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02412-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2412"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02412-w","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]},"assertion":[{"value":"28 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Medical Ethics Committee of Beijing Luhe Hospital, Capital Medical University approved the study protocol (approval number: 2024-LHKY-110-02). All participants provided written informed consent. Ethical conduct was ensured per the principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"304"}}